Skin Vision Enters Into Partnership With German Insurer

A major benefit of the digital transformation of healthcare is improving the speed and accuracy of diagnoses. As the healthcare business model shifts from a fee-for-service business to value-based care, innovative healthcare startups and payers are partnering to reinvent healthcare by enabling patients to take care of themselves. SkinVision and Central launch a skin cancer screening app to offer Central policyholders a mobile phone app to scan their bodies for signs of skin cancer is a prime example

Users take photos of lesions or moles and SkinVision’s app, which uses a clinically tested algorithm, checks for signs of skin cancer in skin spots and surrounding tissue.

The algorithm calculates the fractal dimension of skin lesions and surrounding skin tissue to reveal the different growth patterns of the tissues for its melanoma risk analysis.

The app compares the user’s lesions to the 3.5 million pictures of suspicious skin conditions in the company’s database.


After the scan is complete, the user will receive an assessment within 30 seconds. The user will then receive a low, medium or high risk assessment, along with related advice.

The company says that if a user receives a high risk assessment, SkinVision’s dermatologists would be on hand to offer advice within 48 hours about next steps to take.

The Tech Guide website claims this is the first app of its kind to offer online assessments and determine non-natural growth of pigmented moles.

The app is said to be 83 percent accurate. This will come as good news, since in the past, skeptics have questioned the efficacy of mobile phone apps in detecting skin cancer.

SkinVision chief executive officer, Erik de Heus, said he was “very excited about how this partnership will evolve.”

Jochen Petin, the Chief Insurance Officer of Health at Generali Deutschland, said the use “of intelligent technologies is a central component of our smart insurance offensive.”

SkinVision, which was founded in 2012, says the idea for the app came after the realization that the number of skin cancer cases has been on an upward trend over the last two decades.  The company estimates that about 200,000 people are diagnosed with the disease annually in Germany.

The app is not yet available in the U.S.

Want more about innovation in healthcare? Read an interview with Dr. Simon Stertzer about how the healthcare industry is leveraging biotechnology to treat and prevent heart failure.